Abbott to Acquire Exact Sciences
Exact Sciences is being acquired by Abbott, a global healthcare leader, at a total equity value of approximately $21 billion, the company announced today. “Together with Abbott, we can reach…
Tag Archives: Kevin Conroy
Exact Sciences Launches Cancerguard
Exact Sciences announced recently the launch of Cancerguard, a multi-cancer early detection (MCED) blood test that is now available as a laboratory-developed test (LDT) in the United States. According to…
Exact Sciences, Freenome Enter Agreement
Exact Sciences has entered into an exclusive agreement with Freenome, a biotechnology company pioneering an early cancer detection platform, the company announced recently. According to a release, Exact Sciences will…
Exact Sciences Gives Report on Blood-Based Test
Exact Sciences announced performance data for its blood-based colorectal cancer (CRC) screening test at the European Society of Medical Oncology (ESMO) Congress, the company announced recently. According to a release,…
Exact Sciences Releases Cologuard Data
Exact Sciences shared new modeling data that shows the impact of the Cologuard tests on patients, healthcare professionals and the U.S. healthcare system since its FDA approval a decade ago,…
Exact Sciences to Collaborate With Mayo Clinic
Exact Sciences is collaborating with the Mayo Clinic to provide comprehensive genomic profiling and hereditary cancer tests to patients, the company announced recently. According to a release, the Mayo Clinic…
Exact Sciences Sees Improvement in Next-Gen Cologuard
Exact Sciences plans to submit next-generation Cologuard tests for FDA approval, the company announced recently. According to a release, the results from its BLUE-C study saw 94 percent sensitivity for…
Exact Sciences Acquires PreventionGenetics
Exact Sciences announced recently that it acquired PreventionGenetics, a clinical DNA testing laboratory located in Marshfield, Wis. According to a release, PreventionGenetics will provide the clinical lab, expertise and technology…
Exact Sciences, Jefferson Health Collaborate
Exact Sciences and Jefferson Health are collaborating to conduct research on a new blood-based, multi-cancer earlier detection (MCED) test, the company announced recently. According to a release, the joint effort…
Exact Sciences to Acquire Ashion Analytics
Exact Sciences has acquired Ashion Analytics to help accelerate the development of its precision oncology portfolio, including minimal residual disease (MRD) and other sequencing-based tests, the company announced recently. According…
